staff reporter

Analysts noted that while continued double-digit growth appears unsustainable in the near term, risks related to UnitedHealthcare's decision on pharmacogenetic testing appear limited.

The deal involves the implementation in Limbach Group labs of Noul's automated MiLab instrument that uses microscopy and AI-developed algorithms to analyze samples.

The organization now recommends HPV primary screening every five years starting at age 30 and includes patient-collected HPV screening.

The PD-L1 IHC 28-8 PharmDx test is used to provide information on PD-L1 expression as a biomarker for patient response to therapies containing anti-PD-1 antibodies.

The investment bank said it prefers diagnostics companies with strong commercial engines, although noted it that Hologic and QuidelOrtho are in transition.

The exclusive license agreement builds on an existing research collaboration between the companies to develop assays for skin cancer using Akoya's immunofluorescence platform.

The funding will support the development of the AmplifiDx Dx 100 Platform for use with a nucleic acid amplification test for respiratory infections.

The US Food and Drug Administration granted clearances to tests for infectious diseases, drug resistances, and chronic diseases, among other clearances.

The panel detects pathogens that cause chikungunya, dengue, leptospirosis, and malaria using the firm's BioFire system.

The firm said its T2 Magnetic Resonance technology for testing whole-blood samples could be paired with fluorescence and other testing methods.